Published in Genetics and Environmental Law Weekly, October 30th, 2004
The enzyme is a proprietary development of Prokaria and bears a variety of superior traits that provide the potential for high-end innovations and strong Intellectual Property in a whole set of Polymerase applications thus representing a high commercial value to Prokaria and industrial partners who are interested to join.
The scientific key facts so far established:
-The first thermostable DNA polymerase with high natural strand displacement and proof-reading activity
-Wide temperature range (up to...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Genetics and Environmental Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.